Gotham Asset Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $859K | Sell |
|
|||||
|
2025
Q2 | $1.01M | Sell |
|
|||||
|
2025
Q1 | $1.07M | Sell |
|
|||||
|
2024
Q4 | $1.22M | Sell |
|
|||||
|
2024
Q3 | $1.37M | Buy |
|
|||||
|
2024
Q2 | $828K | Buy |
|
|||||
|
2024
Q1 | $396K | Sell |
|
|||||
|
2023
Q4 | $733K | Sell |
|
|||||
|
2023
Q3 | $685K | Buy |
|
|||||
|
2023
Q2 | $766K | Sell |
|
|||||
|
2023
Q1 | $1.24M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $270K | Buy |
|
|||||
|
2022
Q2 | $232K | Sell |
|
|||||
|
2022
Q1 | $497K | Sell |
|
|||||
|
2021
Q4 | $1.48M | Buy |
|
|||||
|
2021
Q3 | $1.14M | Buy |
|
|||||
|
2021
Q2 | $460K | Buy |
|
|||||
|
2021
Q1 | $510K | Sell |
|
|||||
|
2020
Q4 | $718K | Buy |
|
|||||
|
2020
Q3 | $714K | Sell |
|
|||||
|
2020
Q2 | $714K | Sell |
|
|||||
|
2020
Q1 | $2.02M | Buy |
|
|||||
|
2019
Q4 | $1.3M | Sell |
|
|||||
|
2019
Q3 | $1.94M | Buy |
|
|||||
|
2019
Q2 | $1.89M | Buy |
|
|||||
|
2019
Q1 | $312K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $828K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $673K | Sell |
|
|||||
|
2014
Q2 | $871K | Buy |
|